raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:137698

Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk

Synonyms: CMV disease in patients with impaired cell mediated immunity deemed at risk

Type
Particular clinical situation in a disease or syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

Orphadata ships no English definition for this code.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCytomegalovirus disease in patients with impaired cell mediated immunity deemed at riskCMV disease in patients with impaired cell mediated immunity deemed at risk
frInfection à cytomégalovirus chez des patients à risque avec une immunodépression cellulaireInfection à CMV chez des patients à risque avec une immunodépression cellulaire
deZytomegalievirus-Infektion bei Risiko-Patienten mit eingeschränkter Zell-vermittelter Immunität
esEnfermedad por citomegalovirus (CMV) en pacientes de riesgo por inmunidad celular alterada
itMalattia da citomegalovirus in pazienti a rischio per immunodepressione cellulareMalattia da CMV in pazienti a rischio per immunodepressione cellulare
nlCytomegalovirusziekte met risico voor patiënten met verminderde celgemedieerde immuniteitCMV-ziekte met risico voor patiënten met verminderde celgemedieerde immuniteit
ptInfeção por citomegalovirus (CMV) em doentes de risco com imunidade celular diminuída
plChoroba cytomegalowirusowa u pacjentów zagrożonych upośledzeniem odporności komórkowejChoroba CMV u pacjentów zagrożonych upośledzniem odporności komórkowej
csCytomegalovirová infekce u pacientů s poruchou buněčné imunity považovaných za rizikovéCMV infekce u pacientů s poruchou buňkami zprostředkované imunity považovaných za rizikové
ukЦитомегаловірусна хвороба у пацієнтів з ослабленим клітинним імунітетом, які належать до групи ризикуЗахворювання на ЦМВ у пацієнтів з ослабленим клітинним імунітетом, які належать до групи ризику
zh伴细胞介导免疫功能受损风险患者的巨细胞病毒病细胞免疫受损患者中的巨细胞病毒病
trHücre aracılı bağışıklığı bozulmuş hastalarda riskli kabul edilen sitomegalovirüs hastalığıRiskli kabul edilen, hücre aracılı bağışıklığı bozulmuş hastalarda CMV hastalığı
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10B25.8NTBTattributedvalidated
ICD-111D82.YNTBTattributedvalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00025.5 / 100 000EuropeValue and classValidatedEuropean Medicines Agency 2012[OTHER]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2024-11-27
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0002027Abdominal pain
HP:0002014Diarrhea
HP:0012378Fatigue
HP:0001882Leukopenia
HP:0033834Malaise
HP:6001005Positive gastric CMV intranuclear inclusions
HP:0001873Thrombocytopenia
HP:0006562Viral hepatitis
Occasional (29-5%)
HP:0033431Cytomegalovirus colitis
HP:0001399Hepatic failure
HP:0006515Interstitial pneumonitis
HP:0012486Myelitis
HP:0033993Viral encephalitis
Very rare (<4-1%)
HP:0032118Retinitis

Annotation source: 29083720[PMID]_20481654[PMID]_29596116[PMID]

7

Sources for this card